Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioLineRx (BLRX) Assets Average: 2023-2025

Historic Assets Average for BioLineRx (BLRX) over the last 2 years, with Jun 2025 value amounting to $43.4 million.

  • BioLineRx's Assets Average fell 25.32% to $43.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $43.4 million, marking a year-over-year decrease of 25.32%. This contributed to the annual value of $51.4 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q2 2025, BioLineRx's Assets Average is $43.4 million, which was up 5.29% from $41.2 million recorded in Q1 2025.
  • BioLineRx's Assets Average's 5-year high stood at $63.8 million during Q2 2023, with a 5-year trough of $41.2 million in Q1 2025.
  • In the last 3 years, BioLineRx's Assets Average had a median value of $57.8 million in 2024 and averaged $53.7 million.
  • Per our database at Business Quant, BioLineRx's Assets Average grew by 4.96% in 2024 and then decreased by 28.66% in 2025.
  • Over the past 3 years, BioLineRx's Assets Average (Quarterly) stood at $58.4 million in 2023, then dropped by 21.52% to $45.8 million in 2024, then fell by 25.32% to $43.4 million in 2025.
  • Its last three reported values are $43.4 million in Q2 2025, $41.2 million for Q1 2025, and $45.8 million during Q4 2024.